Gotham Asset Management LLC lessened its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 39.9% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 37,323 shares of the company’s stock after selling 24,739 shares during the period. Gotham Asset Management LLC owned 0.07% of Prestige Consumer Healthcare worth $1,153,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. SG Americas Securities LLC lifted its holdings in shares of Prestige Consumer Healthcare by 6.9% in the 3rd quarter. SG Americas Securities LLC now owns 23,515 shares of the company’s stock valued at $891,000 after acquiring an additional 1,525 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Prestige Consumer Healthcare by 6.5% during the fourth quarter. Geode Capital Management LLC now owns 566,529 shares of the company’s stock worth $17,493,000 after acquiring an additional 34,514 shares during the period. First Hawaiian Bank increased its holdings in Prestige Consumer Healthcare by 218.4% during the fourth quarter. First Hawaiian Bank now owns 1,210 shares of the company’s stock valued at $37,000 after buying an additional 830 shares during the period. First Quadrant L P CA purchased a new position in Prestige Consumer Healthcare during the fourth quarter valued at approximately $72,000. Finally, Xact Kapitalforvaltning AB increased its holdings in Prestige Consumer Healthcare by 24.2% during the fourth quarter. Xact Kapitalforvaltning AB now owns 10,781 shares of the company’s stock valued at $333,000 after buying an additional 2,100 shares during the period.
Several equities analysts recently issued reports on PBH shares. Zacks Investment Research raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating and set a $35.00 price objective on the stock in a report on Wednesday, January 2nd. ValuEngine lowered shares of Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a report on Thursday, January 10th. Raymond James lowered shares of Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating and set a $28.40 price target on the stock. in a report on Tuesday, January 15th. Desjardins lowered shares of Prestige Consumer Healthcare to a “hold” rating and set a $88.00 price target on the stock. in a report on Wednesday, February 13th. Finally, Royal Bank of Canada reaffirmed a “buy” rating and issued a $97.00 price target on shares of Prestige Consumer Healthcare in a report on Friday, March 15th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $54.07.
Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, February 7th. The company reported $0.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.02. The company had revenue of $241.40 million during the quarter, compared to the consensus estimate of $241.40 million. Prestige Consumer Healthcare had a net margin of 6.44% and a return on equity of 11.85%. The firm’s quarterly revenue was down 10.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.70 earnings per share. Equities analysts forecast that Prestige Consumer Healthcare Inc will post 2.77 EPS for the current year.
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Read More: Total Return
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.